Studies of diabetes, thiazolidinediones, and coronary heart disease

Pharmacoepidemiol Drug Saf. 2007 Dec;16(12):1313-4; author reply 1314-6. doi: 10.1002/pds.1498.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Coronary Disease / chemically induced*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Hospitalization / statistics & numerical data
  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Hypoglycemic Agents / therapeutic use
  • Myocardial Infarction / chemically induced
  • Pioglitazone
  • Rosiglitazone
  • Thiazolidinediones / adverse effects*
  • Thiazolidinediones / therapeutic use

Substances

  • Hypoglycemic Agents
  • Thiazolidinediones
  • Rosiglitazone
  • Pioglitazone